We are live on ! Find out more
MRM

Michael R. Murphy Portfolio holdings

AUM $255M
1-Year Est. Return 0.87%
This Fund
S&P 500
This Quarter Est. Return
+8.49%
1 Year Est. Return
+0.87%
3 Year Est. Return
+93.92%
5 Year Est. Return
10 Year Est. Return
AUM
$338M
AUM Growth
+$73.1M
Cap. Flow
+$52.9M
Cap. Flow %
15.67%
Top 10 Hldgs %
66.79%
Holding
25
New
4
Increased
12
Reduced
4
Closed
4

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.33%
2 Technology 20.56%
3 Healthcare 16.76%
4 Consumer Discretionary 15.21%
5 Energy 12.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$37M 10.96%
2,447,247
-3,729,129
-60% -$42.1M
LRN icon
2
Stride
LRN
$3.61B
$23.7M 7.01%
1,045,076
PLXT
3
DELISTED
PLX TECHNOLOGY INC
PLXT
$22.6M 6.7%
3,735,178
+818,808
+28% +$5.04M
ZUMZ icon
4
Zumiez
ZUMZ
$307M
$22.6M 6.69%
931,437
+569,946
+158% +$13.3M
TESO
5
DELISTED
Tesco Corp
TESO
$22M 6.53%
1,191,454
+407,072
+52% +$7.95M
IL
6
DELISTED
IntraLinks Holdings Inc.
IL
$21.3M 6.33%
2,086,886
-800
-0% -$8.73K
CARB
7
DELISTED
Carbonite Inc
CARB
$20.9M 6.19%
2,051,361
+1,138,585
+125% +$12.5M
REN
8
DELISTED
Resolute Energy Corporaton
REN
$20.1M 5.96%
558,586
+382,338
+217% +$16M
BRLI
9
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$18M 5.32%
+649,052
New +$17M
BBRG
10
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
$17.2M 5.1%
1,219,244
+124,383
+11% +$1.88M
FBC
11
DELISTED
Flagstar Bancorp, Inc. New
FBC
$15.7M 4.64%
+705,505
New +$14.9M
RLOC
12
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$15.1M 4.49%
1,537,507
+1,235,591
+409% +$14.4M
SUPN icon
13
Supernus Pharmaceuticals
SUPN
$2.54B
$12M 3.56%
+1,345,031
New +$12.4M
CKSW
14
DELISTED
CLICKSOFTWARE TECH LTD
CKSW
$11.6M 3.43%
1,143,318
-246,124
-18% -$2.32M
PRSU
15
Pursuit Attractions and Hospitality Inc
PRSU
$1.36B
$11.6M 3.42%
480,509
+227,798
+90% +$5.61M
GSIG
16
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
$11.5M 3.39%
876,888
+74,711
+9% +$877K
GILT icon
17
Gilat Satellite Networks
GILT
$766M
$10.2M 3.01%
2,059,833
+193,499
+10% +$976K
EXA
18
DELISTED
EXA Corporation
EXA
$9.73M 2.88%
733,849
-22,490
-3% -$319K
NUTR
19
DELISTED
Nutraceutical International Co
NUTR
$7.55M 2.24%
290,376
+18,574
+7% +$482K
ARX
20
DELISTED
Aeroflex Holding Corp (DE)
ARX
$3.73M 1.1%
+448,650
New +$3.45M
AGYS icon
21
Agilysys
AGYS
$3.32B
$3.5M 1.04%
261,173
+216,021
+478% +$3.04M
APEI icon
22
American Public Education
APEI
$842M
-266,631
Closed -$11.6M
CPF icon
23
Central Pacific Financial
CPF
$974M
-437,053
Closed -$8.78M
CSII
24
DELISTED
Cardiovascular Systems, Inc.
CSII
-341,637
Closed -$11.7M
BIRT
25
DELISTED
Actuate Corp
BIRT
-1,111
Closed -$9K

Similar funds

Michael R. Murphy's Q1 2014 Portfolio in Review

As of Q1 2014, Michael R. Murphy held 25 positions worth $338M, up 28% from $264M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Michael R. Murphy deployed $52.9M of net new capital in Q1 2014, opening 4 new positions and adding to 12 existing holdings. Its largest new stake was BIO-REFERENCE LABS INC-NEW-: 649,052 shares worth $18M.

By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $42.1M trimmed.

  • Michael R. Murphy's largest Q1 2014 buy was BIO-REFERENCE LABS INC-NEW-: 649,052 shares worth $18M.
  • Michael R. Murphy added most to Resolute Energy Corporaton in Q1 2014, an estimated $16M increase.
  • Michael R. Murphy's biggest Q1 2014 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $42.1M.
  • Michael R. Murphy fully exited Cardiovascular Systems, Inc. in Q1 2014, selling an estimated $11.7M.
  • Michael R. Murphy's ten largest holdings make up 67% of its $338M portfolio in Q1 2014.
  • Michael R. Murphy opened 4 new positions and closed 4 in Q1 2014.
  • Michael R. Murphy's portfolio value rose 28% quarter-over-quarter to $338M.

Based on Michael R. Murphy's 13F filing for Q1 2014, filed 14 May 2014.